Sigachi Laboratories Limited

Hyderabad, India
Manufacture of bulk drugs and drug intermediates in Telangana.
Annual revenue $367,504 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Sigachi Laboratories Limited

Sigachi Laboratories Limited is a company based in Hyderabad (India). Sigachi Laboratories Limited offers products and services including Bulk Drugs and Drug Intermediates.

  • Headquarter Hyderabad, India
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Sigachi Laboratories Limited
  • Jurisdiction Na, Telangana, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $367.5 K (USD)
    -21.24
    as on Mar 31, 2022
  • Net Profit
    $241.52 K (USD)
    -27.51
    as on Mar 31, 2022
  • EBITDA
    $254.19 K (USD)
    -28.08
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Sigachi Laboratories Limited

Sigachi Laboratories Limited offers a comprehensive portfolio of products and services, including Bulk Drugs and Drug Intermediates.

Product name locked
Category locked
Primary

Bulk drugs are manufactured for use in medicinal applications within the pharmaceutical industry

Product name locked
Category locked
Locked

Drug intermediates are produced as precursors for bulk drugs in the pharmaceutical sector

Funding Insights of Sigachi Laboratories Limited

Premium access

Detailed funding history for Sigachi Laboratories Limited

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sigachi Laboratories Limited

Investments
Premium access

Investment portfolio details for Sigachi Laboratories Limited

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Sigachi Laboratories Limited

Premium access

Detailed financials for Sigachi Laboratories Limited

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Sigachi Laboratories Limited Comparisons

Sigachi Laboratories Limited Primary company
Description
Manufacture of bulk drugs and drug intermediates in Telangan...
Location
Hyderabad, India
Founded Year
-
Annual Revenue
$367.5 K (USD)
Net Profit
$241.52 K (USD)
EBITDA
$254.19 K (USD)
Employees
Not available
Premium access

Peer comparison for Sigachi Laboratories Limited

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Sigachi Laboratories Limited

Premium access

Detailed competitors of Sigachi Laboratories Limited

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Sigachi Laboratories Limited

Premium access

Complete news archive for Sigachi Laboratories Limited

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sigachi Laboratories Limited

Sigachi Laboratories Limited is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Annual revenue of Sigachi Laboratories Limited is $367.5K as on Mar 31, 2022.

Sigachi Laboratories Limited is primarily involved in the manufacture of bulk drugs and drug intermediates, which are essential components in the pharmaceutical industry. The companys operations are conducted from its registered office in Bonthapally and corporate office in Hyderabad, Telangana, India. Compliance with SEBI regulations is maintained through disclosures of annual reports, financial results, and corporate governance policies. Investor information, including share holding patterns and contact details of key personnel, is regularly updated and made available. The entity ensures adherence to legal standards as outlined in its CIN: L24230TG1994PLC018786, supporting ongoing activities in drug production.

Sigachi Laboratories Limited offers Bulk Drugs and Drug Intermediates.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available